Skip to main content
Top
Published in: BMC Surgery 1/2022

Open Access 01-12-2022 | Liver Resection | Research

Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a western referral center

Authors: João Paulo Maciel Silva, Fabricio Ferreira Coelho, Alex Jones Flores Cassenote, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, José Donizeti de Meira Júnior, Sérgio Carlos Nahas, Paulo Herman

Published in: BMC Surgery | Issue 1/2022

Login to get access

Abstract

Background

Recent studies from eastern centers have demonstrate an association between inflammatory response and long-term outcomes after hepatocellular carcinoma (HCC) resection. However, the prognostic impact of inflammatory markers in western patients, with distinct tumor and epidemiologic features, is still unknown.

Aim

To evaluate the prognostic impact of preoperative neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as well as their impact according to tumor size (< 5 cm, 5–10 cm, > 10 cm) in patients undergoing HCC resection with curative intent.

Methods

Optimal cut-off values for NLR, PLR, and MLR were determined by plotting the receiver operator curves. Overall survival (OS) and disease-free survival (DFS) curves were calculated using the Kaplan–Meier method and compared using the log-rank test. The Cox method was used to identify independent predictors of OS and DFS.

Results

In total, 161 consecutive adult patients were included. A high NLR (> 1.715) was associated with worse OS (P = 0.018). High NLR (> 2.475; P = 0.047) and PLR (> 100.25; P = 0.028) were predictors of short DFS. In HCC < 5 cm, MLR (> 1.715) was associated with worse OS (P = 0.047). In the multivariate analysis, high PLR was an independent predictor of worse DFS [hazard ratio (HR) 3.029; 95%CI 1.499–6.121; P = 0.002].

Conclusion

Inflammatory markers are useful tools to predict long-term outcomes after liver resection in western patients, high NLR was able to stratify subgroups of patients with short OS and DFS, an increased PLR was an independent predictor of short DFS, while high MLR was associated with short OS in patients with early HCC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chagas AL, Mattos AA, Carrilho FJ, Bittencourt PL, Vezozzo DCP, Horvat N, et al. Brazilian Society of Hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma. Arq Gastroenterol. 2020;57(1):1–20.PubMedCrossRef Chagas AL, Mattos AA, Carrilho FJ, Bittencourt PL, Vezozzo DCP, Horvat N, et al. Brazilian Society of Hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma. Arq Gastroenterol. 2020;57(1):1–20.PubMedCrossRef
2.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.PubMedCrossRef Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.PubMedCrossRef
3.
go back to reference Lopes F, Coelho FF, Kruger JAP, Fonseca GM, de Araujo RLC, Jeismann VB, et al. Influence of hepatocellular carcinoma etiology in the survival after resection. Arq Bras Cir Dig. 2016;29(2):105–8.PubMedCentralCrossRef Lopes F, Coelho FF, Kruger JAP, Fonseca GM, de Araujo RLC, Jeismann VB, et al. Influence of hepatocellular carcinoma etiology in the survival after resection. Arq Bras Cir Dig. 2016;29(2):105–8.PubMedCentralCrossRef
4.
go back to reference Cay MY, Wang FW, Li CP, Yan LX, Chen JW, Luo RZ, et al. Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma. Chin J Cancer. 2016;35(1):1–7.CrossRef Cay MY, Wang FW, Li CP, Yan LX, Chen JW, Luo RZ, et al. Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma. Chin J Cancer. 2016;35(1):1–7.CrossRef
5.
go back to reference Szor DJ, Dias AR, Pereira MA, Ramos MFKP, Zilberstein B, Cecconello I, et al. Neutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancer. J Surg Oncol. 2018;117(5):851–7.PubMedCrossRef Szor DJ, Dias AR, Pereira MA, Ramos MFKP, Zilberstein B, Cecconello I, et al. Neutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancer. J Surg Oncol. 2018;117(5):851–7.PubMedCrossRef
6.
go back to reference Pointer DT, Roife D, Powers BD, Murimwa G, Elessawy S, Thompson ZJ, et al. Neutrophil to lymphocyte ratio not platelet to lymphocyte or lymphocyte to monocyte ratio is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. BMC Cancer. 2020;20(1):1–11.CrossRef Pointer DT, Roife D, Powers BD, Murimwa G, Elessawy S, Thompson ZJ, et al. Neutrophil to lymphocyte ratio not platelet to lymphocyte or lymphocyte to monocyte ratio is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. BMC Cancer. 2020;20(1):1–11.CrossRef
7.
go back to reference Yang HL, Guo Z, Yang YT, Jiang JH, Qi YP, Li JJ, et al. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: a propensity score-based analysis. World J Gastroenterol. 2016;22(21):5088–95.PubMedPubMedCentralCrossRef Yang HL, Guo Z, Yang YT, Jiang JH, Qi YP, Li JJ, et al. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: a propensity score-based analysis. World J Gastroenterol. 2016;22(21):5088–95.PubMedPubMedCentralCrossRef
8.
go back to reference Liao R, Tang ZW, Li DW, Luo SQ, Huang P, Du CY. Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report. World J Surg Oncol. 2015;13:1–8.CrossRef Liao R, Tang ZW, Li DW, Luo SQ, Huang P, Du CY. Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report. World J Surg Oncol. 2015;13:1–8.CrossRef
9.
go back to reference Goh BKP, Kam JH, Lee SY, Chan CY, Allen JC, Jeyaraj P, et al. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index as preoperative predictors of early mortality after liver resection for huge (≥ 10 cm) hepatocellular carcinoma. J Surg Oncol. 2016;113:621–7.PubMedCrossRef Goh BKP, Kam JH, Lee SY, Chan CY, Allen JC, Jeyaraj P, et al. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index as preoperative predictors of early mortality after liver resection for huge (≥ 10 cm) hepatocellular carcinoma. J Surg Oncol. 2016;113:621–7.PubMedCrossRef
10.
go back to reference Sullivan KM, Groeschi RT, Turaga KK, Tsai S, Christians KK, White SB, et al. Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. J Surg Oncol. 2014;109(2):95–7.PubMedCrossRef Sullivan KM, Groeschi RT, Turaga KK, Tsai S, Christians KK, White SB, et al. Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. J Surg Oncol. 2014;109(2):95–7.PubMedCrossRef
11.
go back to reference Hu DH, Yu SM. Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): a meta-analysis. Cell Mol Biol. 2017;63(8):30–2.PubMedCrossRef Hu DH, Yu SM. Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): a meta-analysis. Cell Mol Biol. 2017;63(8):30–2.PubMedCrossRef
12.
go back to reference Zheng J, Seier K, Gonen M, Balachandran VP, Kingham TP, D’Angelica MI, Allen PJ, Jarnagin WR, DeMatteo RP. Utility of serum inflammatory markers for predicting microvascular invasion and survival for patients with hepatocellular carcinoma. Ann Surg Oncol. 2017;24(12):3706–14.PubMedPubMedCentralCrossRef Zheng J, Seier K, Gonen M, Balachandran VP, Kingham TP, D’Angelica MI, Allen PJ, Jarnagin WR, DeMatteo RP. Utility of serum inflammatory markers for predicting microvascular invasion and survival for patients with hepatocellular carcinoma. Ann Surg Oncol. 2017;24(12):3706–14.PubMedPubMedCentralCrossRef
13.
go back to reference Choen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11):e012799.CrossRef Choen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11):e012799.CrossRef
14.
go back to reference Herman P, Perini MV, Coelho FF, Kruger JAP, Lupinacci RM, Fonseca GM, et al. Laparoscopic resection of hepatocellular carcinoma: when, why and how? A single-center experience. J Laparoendosc Adv Surg Tech. 2014;24(4):223–8.CrossRef Herman P, Perini MV, Coelho FF, Kruger JAP, Lupinacci RM, Fonseca GM, et al. Laparoscopic resection of hepatocellular carcinoma: when, why and how? A single-center experience. J Laparoendosc Adv Surg Tech. 2014;24(4):223–8.CrossRef
15.
go back to reference Galon J, Angeli HK, Bedognetti D, Marincola F. The continuum of cancer immunosurveillance: prognostic, predictive and mechanistic signatures. Immunity. 2013;39(1):11–26.PubMedCrossRef Galon J, Angeli HK, Bedognetti D, Marincola F. The continuum of cancer immunosurveillance: prognostic, predictive and mechanistic signatures. Immunity. 2013;39(1):11–26.PubMedCrossRef
16.
go back to reference Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumors, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759–71.PubMedCrossRef Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumors, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759–71.PubMedCrossRef
17.
go back to reference Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell. 2018;33:965–83.PubMedPubMedCentralCrossRef Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell. 2018;33:965–83.PubMedPubMedCentralCrossRef
18.
go back to reference Huong PT, Nguyen LT, Nguyen BX, Lee SK, Bach DH. The role of platelets in the tumor-microenvironment and the drug resistance of cancer cells. Cancers. 2019;11(2):240.PubMedCentralCrossRef Huong PT, Nguyen LT, Nguyen BX, Lee SK, Bach DH. The role of platelets in the tumor-microenvironment and the drug resistance of cancer cells. Cancers. 2019;11(2):240.PubMedCentralCrossRef
19.
go back to reference Bowen RC, Little NAB, Harmer JR, Ma J, Mirabelli LG, Roller KD, et al. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(19):32171–89.PubMedPubMedCentralCrossRef Bowen RC, Little NAB, Harmer JR, Ma J, Mirabelli LG, Roller KD, et al. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(19):32171–89.PubMedPubMedCentralCrossRef
20.
go back to reference Hirashima M, Higuchi S, Sakamoto K, Nishiyama T, Okada H. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol. 1998;124(6):329–34.PubMedCrossRef Hirashima M, Higuchi S, Sakamoto K, Nishiyama T, Okada H. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol. 1998;124(6):329–34.PubMedCrossRef
21.
go back to reference Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100:888–97.PubMedPubMedCentralCrossRef Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100:888–97.PubMedPubMedCentralCrossRef
22.
go back to reference Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ration in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.PubMedCrossRef Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ration in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.PubMedCrossRef
23.
go back to reference Wang Y, Peng C, Cheng Z, Wang X, Wu L, Li J, et al. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: a systematic review and meta-analysis. Int J Surg. 2018;55:73–80.PubMedCrossRef Wang Y, Peng C, Cheng Z, Wang X, Wu L, Li J, et al. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: a systematic review and meta-analysis. Int J Surg. 2018;55:73–80.PubMedCrossRef
24.
go back to reference Choo SP, Tan WLT, Goh BKP, Tai WM, Zhu AX. Comparison of hepatocellular carcinoma in eastern and western populations. Cancer. 2006;122:3430–46.CrossRef Choo SP, Tan WLT, Goh BKP, Tai WM, Zhu AX. Comparison of hepatocellular carcinoma in eastern and western populations. Cancer. 2006;122:3430–46.CrossRef
25.
go back to reference Tanaka J, Koyama T, Mizui M, Uchida S, Katayama K, Matsuo J, et al. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale. Intervirology. 2011;54:185–95.PubMedCrossRef Tanaka J, Koyama T, Mizui M, Uchida S, Katayama K, Matsuo J, et al. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale. Intervirology. 2011;54:185–95.PubMedCrossRef
26.
go back to reference Beard RE, Hanto DW, Gautam S, Miksad RA. A comparison of surgical outcomes for noncirrhotic and cirrhotic hepatocellular carcinoma patients in a Western institution. Surgery. 2013;154(3):545–55.PubMedCrossRef Beard RE, Hanto DW, Gautam S, Miksad RA. A comparison of surgical outcomes for noncirrhotic and cirrhotic hepatocellular carcinoma patients in a Western institution. Surgery. 2013;154(3):545–55.PubMedCrossRef
27.
go back to reference Chen Q, Li F, Zhong C, Zou Y, Li Z, Gao Y, et al. Inflammatory score system using preoperative inflammatory markers to predict prognosis for hepatocellular carcinoma after hepatectomy: a cohort study. J Cancer. 2020;11(17):4947–56.PubMedPubMedCentralCrossRef Chen Q, Li F, Zhong C, Zou Y, Li Z, Gao Y, et al. Inflammatory score system using preoperative inflammatory markers to predict prognosis for hepatocellular carcinoma after hepatectomy: a cohort study. J Cancer. 2020;11(17):4947–56.PubMedPubMedCentralCrossRef
28.
go back to reference Xingshun Qi Jianjun, Li Han, Deng. Neutrophil-to-lymphocityte ratio for the prognostic assessment of hepatocellular carcinoma: a systematic review and meta-analysis of observational studies. Oncotarget. 2016;7(29):45282–301. Xingshun Qi Jianjun, Li Han, Deng. Neutrophil-to-lymphocityte ratio for the prognostic assessment of hepatocellular carcinoma: a systematic review and meta-analysis of observational studies. Oncotarget. 2016;7(29):45282–301.
29.
go back to reference Young AL, Adair R, Prasad KR, Toogood GJ, Lodge JPA. Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. J Am Coll Surg. 2012;214(2):174–83.PubMedCrossRef Young AL, Adair R, Prasad KR, Toogood GJ, Lodge JPA. Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. J Am Coll Surg. 2012;214(2):174–83.PubMedCrossRef
30.
go back to reference Lin ZX, Ruan DY, Li Y, Ma XK, Chen J, Chen ZH, et al. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection. World J Gastroenterol. 2015;21(38):10898–906.PubMedPubMedCentralCrossRef Lin ZX, Ruan DY, Li Y, Ma XK, Chen J, Chen ZH, et al. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection. World J Gastroenterol. 2015;21(38):10898–906.PubMedPubMedCentralCrossRef
31.
go back to reference Qing P, Zhang JY, Xu XS, Song SD, Qu K, Chen W, et al. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. World J Gastroenterol. 2015;21:5607–21.CrossRef Qing P, Zhang JY, Xu XS, Song SD, Qu K, Chen W, et al. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. World J Gastroenterol. 2015;21:5607–21.CrossRef
32.
go back to reference Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Higashi T, et al. Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma. Hepatol Res. 2018;47(10):991–9.CrossRef Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Higashi T, et al. Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma. Hepatol Res. 2018;47(10):991–9.CrossRef
33.
go back to reference Yang YT, Jiang JH, Yang HJ, Wu ZJ, Xiao ZM, Xiang BD. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection. Sci Rep. 2018;7(8):1–7. Yang YT, Jiang JH, Yang HJ, Wu ZJ, Xiao ZM, Xiang BD. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection. Sci Rep. 2018;7(8):1–7.
34.
go back to reference Shirabe K, Mano Y, Muto J, Matono R, Motomura T, Toshima T, et al. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today. 2012;42:1–7.PubMedCrossRef Shirabe K, Mano Y, Muto J, Matono R, Motomura T, Toshima T, et al. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today. 2012;42:1–7.PubMedCrossRef
35.
go back to reference He W, Zeng Q, Zheng Y, Chen M, Shen J, Qiu J, Chen M, Zou R, Liao Y, Li Q, Wu X, Li B, Yuan Y. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis. BMC Cancer. 2015;15(1):1–11.PubMedPubMedCentralCrossRef He W, Zeng Q, Zheng Y, Chen M, Shen J, Qiu J, Chen M, Zou R, Liao Y, Li Q, Wu X, Li B, Yuan Y. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis. BMC Cancer. 2015;15(1):1–11.PubMedPubMedCentralCrossRef
36.
go back to reference Choi SB, Kim HJ, Song TJ, Ahn HS, Choi SY. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci. 2014;21:639–47.PubMedCrossRef Choi SB, Kim HJ, Song TJ, Ahn HS, Choi SY. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci. 2014;21:639–47.PubMedCrossRef
37.
go back to reference Wang ZX, Jiang CP, Cao Y, Zhang G, Chen WB, Ding YT. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2015;14:178–85.PubMedCrossRef Wang ZX, Jiang CP, Cao Y, Zhang G, Chen WB, Ding YT. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2015;14:178–85.PubMedCrossRef
38.
go back to reference Sumie S, Nakashima O, Okuda K, Kuromatsu R, Kawaguchi A, Nakano M, et al. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma. Ann Surg Oncol. 2014;21:1002–9.PubMedCrossRef Sumie S, Nakashima O, Okuda K, Kuromatsu R, Kawaguchi A, Nakano M, et al. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma. Ann Surg Oncol. 2014;21:1002–9.PubMedCrossRef
Metadata
Title
Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a western referral center
Authors
João Paulo Maciel Silva
Fabricio Ferreira Coelho
Alex Jones Flores Cassenote
Vagner Birk Jeismann
Gilton Marques Fonseca
Jaime Arthur Pirola Kruger
José Donizeti de Meira Júnior
Sérgio Carlos Nahas
Paulo Herman
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2022
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-022-01779-6

Other articles of this Issue 1/2022

BMC Surgery 1/2022 Go to the issue